difference between compounded tirzepatide and zepbound TrimRX Compounded Tirzepatide vs Zepbound: Side-by-Side

fail to meet work obligations

Location: Indianapolis, IndianaWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Zepbound (tirzepatide) and Mounjaro (tirzepatide)FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Eli Lilly promoted Mounjaro and Zepbound in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner, despite FDAs prior correspondence (advisory comments dated June 13, 2022 and June 21, 2022)

Poor sleep increases ghrelin (the hunger hormone) and decreases leptin (the satiety hormone), potentially overriding Ozempic's appetite-suppressing effects

The FDA approved semaglutide for chronic weight loss management in adults with a body mass index (BMI) of 30 kg/m2 or higher or those with a BMI of 27 kg/m2 or higher and at least one weight-related ailment, such as high cholesterol, high blood pressure, or type 2 diabetes

Current shortage status of other GLP-1 products (as of February 21, 2025): FDA continues to actively monitor drug availability and is currently working to determine whether the demand or projected demand for each drug in shortage exceeds the available supply

Similarly, via the leaky blood-brain barrier during inflammation (Galea, 2021), CRP enters the central nervous system, where it stimulates microglia and astrocytes to activate central sensitization (Hsuchou et al., 2012)